NAT-ABIRATERONE
Identification of Nat-Abiraterone
| No description |
Google image searchProduct monograph
Active ingredient
abiraterone acetate, 250 MG
DIN: 02494132
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
Date: 18-JAN-2021
ATC:
- L02 — ENDOCRINE THERAPY (ATC, ATC/DDD, )
- L02B — HORMONE ANTAGONISTS AND RELATED AGENTS (ATC, ATC/DDD)
- L02BX — Other hormone antagonists and related agents (ATC, ATC/DDD)
- L02BX03 — ABIRATERONE (ATC/DDD)
Reference brand drug: Zytiga
Pharmaceutical standard: USP
